找化学品上960化工网!
960化工网

黄芪皂苷 Ⅳ | 84687-43-4

黄芪皂苷 Ⅳ
Astragaloside IV
84687-43-4
C41H68O14
784.970234870911
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:黄芪皂苷 Ⅳ结构式
329831290
黄芪皂苷 Ⅳ价格
简介
Astragaloside IV 是从黄芪中分到的皂苷类物质,能够抑制 ERK1/2 和 JNK 的激活,在乳腺癌细胞 MDA-MB-231 中,能够下调 (MMP)-2,(MMP)-9 的信号通路。
名称和标识符
MDL MFCD16036240
InChIKey QMNWISYXSJWHRY-YLNUDOOFSA-N
Inchi 1S/C41H68O14/c1-35(2)24(54-33-29(48)26(45)20(44)17-51-33)9-11-41-18-40(41)13-12-37(5)31(39(7)10-8-25(55-39)36(3,4)50)19(43)15-38(37,6)23(40)14-21(32(35)41)52-34-30(49)28(47)27(46)22(16-42)53-34/h19-34,42-50H,8-18H2,1-7H3/t19-,20+,21-,22+,23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33-,34+,37+,38-,39+,40-,41+/m0/s1
SMILES C[C@@]12C[C@H](O)[C@H]([C@]3(CC[C@@H](C(O)(C)C)O3)C)[C@@]1(C)CC[C@@]13C[C@]41CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)[C@@H]4[C@H](C[C@@H]23)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1
别名信息
- 中文别名 -
  • 黄芪甲苷
  • 黄芪皂苷IV
  • 黄芪皂苷XIV
  • 黄芪甙
  • 黄芪甲苷IV
  • WAKO015-20691Ⅳ黄芪甲苷
  • 黄芪多糖
  • 黄芪甲甙
  • 黄芪甲苷 USP标准品
  • 黄芪甲苷(标准品)
  • 黄芪甲苷IV(P)
  • 黄芪甲苷标准品
  • 黄芪甲苷对照品
  • 黄芪提取物黄
  • 黄芪皂苷Ⅲ
  • 黄芪总皂苷
  • 灵芝多糖
  • 硝苯地平
  • 猪苓多糖
  • 分析对照品
  • 黄芪皂苷Ⅳ
  • 黄芪甲苷 IV 标准品
  • 黄芪提取物
  • 黄芪皂甙
  • 黄芪甲苷
  • 黄芪皂苷IV
  • 黄芪皂苷 IV
  • 黄芪甲苷 IV
  • 黄芪甲苷(标定对照品)
- 英文别名 -
  • ASTRAGALOSIDE
  • 9,19-CYCLOLANOSTANE-BETA-D-GLUCOPYRANOSIDE
  • ASTRAGALOSIDE IV
  • Astrasieversianin XIV
  • β-D-Glucopyranoside, (3β,6α,16β,20R,24S)-
  • Astragaloside Ⅳ
  • ASTRAGALOSIDE IV(P)
  • ASTRAGALOSIDE IV(RG)
  • beta-D-Glucopyranoside, (3beta,6alpha,16beta,20R,24S)-20,24-epoxy-16,25-dihydroxy-3-(beta-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl
  • Astragalus P.E
  • Astragalus extract
  • Astragalus Polysaccharides
  • CH83947
  • CH90651
  • cyclosieversioside F
  • cyclosiversioside F
  • KT Astragaloside IV
  • 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene,b-D-glucopyranoside deriv.
  • 9,19-Cyclolanostane, b-D-glucopyranoside deriv.
  • Astraversianin XIV
  • Astragalus Root Extract
  • AstragalosideIV
  • (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl
  • (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • Astragaloside IV
  • (3β,6α,16β,20R,24S)-20,24-Epoxy-16,25-dihydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl β-D-glucopyranoside (ACI)
  • 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, β-D-glucopyranoside deriv. (ZCI)
  • 9,19-Cyclolanostane, β-D-glucopyranoside deriv. (ZCI)
  • Cyclosieversioside F
  • Cyclosiversioside F
  • Astragaloside Iv,(S)
  • 84687-43-4
  • FT-0686574
  • 83207-58-3
  • NS00018369
  • (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.0^{1,3.0^{3,8.0^{12,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • 2-Hydroxy-1-(5-(1-hydroxy-1-methylethyl)-2-methyltetrahydro-2-furanyl)-3a,6,6,12a-tetramethyl-7-(pentopyranosyloxy)tetradecahydro-1H-cyclopenta[a]cyclopropa[e]phenanthren-5-yl hexopyranoside
  • NSC650944
  • SY067110
  • (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.0^{1,3.0^{3,8.0^{12,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • 16,25-Dihydroxy-3-(pentopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl hexopyranoside
  • MFCD16036240
  • 2-[hydroxy-[5-(1-hydroxy-1-methyl-ethyl)-2-methyl-tetrahydrofuran-2-yl]-tetramethyl-(3,4,5-trihydroxytetrahydropyran-2-yl)oxy-[?]yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
  • DTXSID70868831
  • 1ST40060
  • C17799
  • (2R,3R,4S,5S,6R)-2-[[(1S,3R,8R,9S,11S,12S,14S,15R,16R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • HMS3885E12
  • ASTRAGALOSIDE IV (CONSTITUENT OF ASTRAGALUS) [DSC]
  • ASTRAVERSIANIN XIV
  • CHEBI:65457
  • Astragaloside IV, United States Pharmacopeia (USP) Reference Standard
  • (2R,3R,4S,5S,6R)-2-(((2aR,3R,4S,5aS,5bS,7S,7aR,9S,11aR,12aS)-4-hydroxy-3-((2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-2a,5a,8,8-tetramethyl-9-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthren-7-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
  • HY-N0431
  • 3-O-beta-D-xylopyranosyl-6-O-beta-D-glucopyranosylcycloastragenol
  • AS-19402
  • ASTRAGALOSIDE IV [USP-RS]
  • CHEMBL3121562
  • 1J6XA9YCFV
  • DTXSID801026063
  • Q27133900
  • AST-IV
  • s3901
  • CCG-270470
  • Astragaloside IV 95%
  • UNII-1J6XA9YCFV
  • Astramembrannin I
  • Astragalin A
  • AKOS025311424
  • Astragaloside IV, >98.0%
  • AS-IV
  • SCHEMBL21888259
  • (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • Astragaloside IV, European Pharmacopoeia (EP) Reference Standard
  • .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,16.BETA.,20R,24S)-20,24-EPOXY-16,25-DIHYDROXY-3-(.BETA.-D-XYLOPYRANOSYLOXY)-9,19-CYCLOLANOSTAN-6-YL
  • Astragaloside A
物化性质
实验特性
LogP 0.72410
PSA 228.22000
折射率 1.62
沸点 895.7±65.0 °C at 760 mmHg
熔点 295-296 °C (lit.)
闪点 495.5±34.3 °C
颜色与性状 Powder
密度 1.39
计算特性
精确分子量 784.46100
氢键供体数量 9
氢键受体数量 14
可旋转化学键数量 7
同位素质量 784.46090684 g/mol
重原子数量 55
复杂度 1460
同位素原子数量 0
确定原子立构中心数量 5
不确定原子立构中心数量 16
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 1.3
拓扑分子极性表面积 228
分子量 785.0
海关数据
海关编码 2932999099
海关数据

中国海关编码:

2932999099

概述:

2932999099. 其他仅含氧杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途

Summary:

2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

专业数据库参考
PubChemId 329831290
参考资料
Reaxys RN
黄芪皂苷 Ⅳ推荐生产厂家
960化工网为您提供黄芪皂苷 Ⅳ专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:84687-43-4,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等
平台客服 平台客服

平台在线客服